Next, an ATM mutant plasmid (ATMD1853N) was constructed and introduced into SK-CO-1 cells using a lentiviral system to validate the findings in a model more closely resembling the ATM mutations found in clinical CRC patients [28, 29]. This evidence concerns the gene ATM and colorectal carcinoma.